Gene expression signatures predictive of bevacizumab/erlotinib therapeutic benefit in advanced non-squamous non-small cell lung cancer patients (SAKK 19/05 trial)
12.10.2018
| Title | Gene expression signatures predictive of bevacizumab/erlotinib therapeutic benefit in advanced non-squamous non-small cell lung cancer patients (SAKK 19/05 trial) |
| Publication Type | Journal Article |
| Year of Publication | 2015 |
| Authors | Franzini, A., Baty F., Macovei I. I., Dürr O., Droege C., Betticher D., Grigoriu B. D., Klingbiel D., Zappa F., & Brutsche M. |
| Journal | Clinical Cancer Research |
| Pagination | clincanres––3135 |
